{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:30:34Z","timestamp":1794324634756,"version":"4.9.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS119689"],"award-info":[{"award-number":["NS119689"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS119689"],"award-info":[{"award-number":["NS119689"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41596-022-00787-3","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:04:18Z","timestamp":1674043458000},"page":"1179-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-8389","authenticated-orcid":false,"given":"Luis","family":"Concha-Marambio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pritzkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahnawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly M.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3412-0524","authenticated-orcid":false,"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"787_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"787_CR2","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"787_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer, D. & Edwards, R. H. The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s Disease. J. Neurochem. 150, 475\u2013486 (2019).","journal-title":"J. Neurochem."},{"key":"787_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra, S., Sahay, S. & Maji, S. K. \u03b1-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim. Biophys. Acta Proteins Proteom. 1867, 890\u2013908 (2019).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"787_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","volume":"373","author":"JA Steiner","year":"2018","unstructured":"Steiner, J. A., Quansah, E. & Brundin, P. The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res. 373, 161\u2013173 (2018).","journal-title":"Cell Tissue Res."},{"key":"787_CR6","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363\u201313383 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"787_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1056\/NEJMoa1404401","volume":"371","author":"F Moda","year":"2014","unstructured":"Moda, F. et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N. Engl. J. Med. 371, 530\u2013539 (2014).","journal-title":"N. Engl. J. Med."},{"key":"787_CR8","doi-asserted-by":"publisher","first-page":"370ra183","DOI":"10.1126\/scitranslmed.aaf6188","volume":"8","author":"L Concha-Marambio","year":"2016","unstructured":"Concha-Marambio, L. et al. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci. Transl. Med. 8, 370ra183 (2016).","journal-title":"Sci. Transl. Med."},{"key":"787_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3201\/eid2601.181423","volume":"26","author":"L Concha-Marambio","year":"2020","unstructured":"Concha-Marambio, L., Chacon, M. A. & Soto, C. Preclinical detection of prions in blood of nonhuman primates infected with variant Creutzfeldt-Jakob disease. Emerg. Infect. Dis. 26, 34\u201343 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"787_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/ijms21030880","volume":"21","author":"M Fiorini","year":"2020","unstructured":"Fiorini, M. et al. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int. J. Mol. Sci. 21, 880 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"787_CR11","doi-asserted-by":"publisher","first-page":"e02451-14","DOI":"10.1128\/mBio.02451-14","volume":"6","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa, C. D. et al. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio 6, e02451-14 (2015).","journal-title":"mBio"},{"key":"787_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orr\u00fa","year":"2014","unstructured":"Orr\u00fa, C. D. et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N. Engl. J. Med. 371, 519\u2013529 (2014).","journal-title":"N. Engl. J. Med."},{"key":"787_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul, G. et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812\u2013818 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"787_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz, M. et al. Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 74, 163\u2013172 (2017).","journal-title":"JAMA Neurol."},{"key":"787_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.378","volume":"4","author":"BR Groveman","year":"2017","unstructured":"Groveman, B. R. et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann. Clin. Transl. Neurol. 4, 139\u2013144 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"787_CR16","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/mds.28715","volume":"36","author":"L Concha-Marambio","year":"2021","unstructured":"Concha-Marambio, L. et al. Seed amplification assay to diagnose early Parkinson\u2019s and predict dopaminergic deficit progression. Mov. Disord. 36, 2444\u20132446 (2021).","journal-title":"Mov. Disord."},{"key":"787_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo, M. J. et al. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol. Commun. 9, 179 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"787_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cll.2020.04.002","volume":"40","author":"NDC Ferreira","year":"2020","unstructured":"Ferreira, N. D. C. & Caughey, B. Proteopathic seed amplification assays for neurodegenerative disorders. Clin. Lab. Med. 40, 257\u2013270 (2020).","journal-title":"Clin. Lab. Med."},{"key":"787_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang, U. J. et al. Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov. Disord. 34, 536\u2013544 (2019).","journal-title":"Mov. Disord."},{"key":"787_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4939-9124-2_4","volume":"1948","author":"L Concha-Marambio","year":"2019","unstructured":"Concha-Marambio, L., Shahnawaz, M. & Soto, C. Detection of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid by the protein misfolding cyclic amplification platform. Methods Mol. Biol. 1948, 35\u201344 (2019).","journal-title":"Methods Mol. Biol."},{"key":"787_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz, M. et al. Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578, 273\u2013277 (2020).","journal-title":"Nature"},{"key":"787_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"787_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.39695","volume":"8","author":"A Narayanan","year":"2019","unstructured":"Narayanan, A. et al. A first order phase transition mechanism underlies protein aggregation in mammalian cells. Elife 8, 1\u201326 (2019).","journal-title":"Elife"},{"key":"787_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/370471a0","volume":"370","author":"DA Kocisko","year":"1994","unstructured":"Kocisko, D. A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471\u2013474 (1994).","journal-title":"Nature"},{"key":"787_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett, J. T. & Lansbury, P. T. Seeding \u2018one-dimensional crystallization\u2019 of amyloid: a pathogenic mechanism in Alzheimer\u2019s disease and scrapie? Cell 73, 1055\u20131058 (1993).","journal-title":"Cell"},{"key":"787_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"787_CR27","doi-asserted-by":"publisher","first-page":"35245","DOI":"10.1074\/jbc.M603964200","volume":"281","author":"P Sa\u00e1","year":"2006","unstructured":"Sa\u00e1, P., Castilla, J. & Soto, C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281, 35245\u201335252 (2006).","journal-title":"J. Biol. Chem."},{"key":"787_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nm1286","volume":"11","author":"J Castilla","year":"2005","unstructured":"Castilla, J., Sa\u00e1, P. & Soto, C. Detection of prions in blood. Nat. Med. 11, 982\u2013985 (2005).","journal-title":"Nat. Med."},{"key":"787_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.1129051","volume":"313","author":"P Sa\u00e1","year":"2006","unstructured":"Sa\u00e1, P., Castilla, J. & Soto, C. Presymptomatic detection of prions in blood. Science 313, 92\u201394 (2006).","journal-title":"Science"},{"key":"787_CR30","doi-asserted-by":"publisher","first-page":"370ra182","DOI":"10.1126\/scitranslmed.aag1257","volume":"8","author":"D Bougard","year":"2016","unstructured":"Bougard, D. et al. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci. Transl. Med. 8, 370ra182 (2016).","journal-title":"Sci. Transl. Med."},{"key":"787_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nmeth1066","volume":"4","author":"R Atarashi","year":"2007","unstructured":"Atarashi, R. et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4, 645\u2013650 (2007).","journal-title":"Nat. Methods"},{"key":"787_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nmeth0308-211","volume":"5","author":"R Atarashi","year":"2008","unstructured":"Atarashi, R. et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5, 211\u2013212 (2008).","journal-title":"Nat. Methods"},{"key":"787_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi, R. et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17, 175\u2013178 (2011).","journal-title":"Nat. Med."},{"key":"787_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/ijms18030478","volume":"18","author":"J Pujols","year":"2017","unstructured":"Pujols, J. et al. High-throughput screening methodology to identify alpha-synuclein aggregation inhibitors. Int. J. Mol. Sci. 18, 478 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"787_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.chembiol.2018.08.005","volume":"25","author":"M Kurnik","year":"2018","unstructured":"Kurnik, M. et al. Potent \u03b1-synuclein aggregation inhibitors, identified by high-throughput screening, mainly target the monomeric state. Cell Chem. Biol. 25, 1389\u20131402.e9 (2018).","journal-title":"Cell Chem. Biol."},{"key":"787_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman, B. R. et al. Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol. Commun. 6, 7 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"787_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti, L. et al. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 18, 573\u2013586 (2019).","journal-title":"Lancet Neurol."},{"key":"787_CR38","doi-asserted-by":"publisher","first-page":"eaam6003","DOI":"10.1126\/scitranslmed.aam6003","volume":"10","author":"AS Chen-Plotkin","year":"2018","unstructured":"Chen-Plotkin, A. S. et al. Finding useful biomarkers for Parkinson\u2019s disease. Sci. Transl. Med. 10, eaam6003 (2018).","journal-title":"Sci. Transl. Med."},{"key":"787_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh, F. N. & Surguchov, A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front. Neurosci. 12, 612 (2018).","journal-title":"Front. Neurosci."},{"key":"787_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma, S. et al. Biomarkers in Parkinson\u2019s disease (recent update). Neurochem. Int. 63, 201\u2013229 (2013).","journal-title":"Neurochem. Int."},{"key":"787_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik, A., Stewart, T. & Zhang, J. Alpha-synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol. 26, 410\u2013418 (2016).","journal-title":"Brain Pathol."},{"key":"787_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/00207454.2014.961454","volume":"125","author":"L Gao","year":"2015","unstructured":"Gao, L. et al. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int. J. Neurosci. 125, 645\u2013654 (2015).","journal-title":"Int. J. Neurosci."},{"key":"787_CR43","doi-asserted-by":"publisher","first-page":"702639","DOI":"10.3389\/fnagi.2021.702639","volume":"13","author":"U Ganguly","year":"2021","unstructured":"Ganguly, U. et al. Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough. Front. Aging Neurosci. 13, 702639 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"787_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jnc.14569","volume":"149","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer, B. et al. Antibody-based methods for the measurement of \u03b1-synuclein concentration in human cerebrospinal fluid\u2014method comparison and round robin study. J. Neurochem. 149, 126\u2013138 (2019).","journal-title":"J. Neurochem."},{"key":"787_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","volume":"450","author":"A Ohrfelt","year":"2009","unstructured":"Ohrfelt, A. et al. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders\u2014a marker of synapse loss? Neurosci. Lett. 450, 332\u2013335 (2009).","journal-title":"Neurosci. Lett."},{"key":"787_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"787_CR47","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi, P. et al. Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 32, 1389\u20131400 (2017).","journal-title":"Mov. Disord."},{"key":"787_CR48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571\u2013576 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"787_CR49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fnins.2016.00408","volume":"10","author":"M Ingelsson","year":"2016","unstructured":"Ingelsson, M. Alpha-synuclein oligomers\u2014neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders. Front. Neurosci. 10, 408 (2016).","journal-title":"Front. Neurosci."},{"key":"787_CR50","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda, T. et al. Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75, 1766\u20131772 (2010).","journal-title":"Neurology"},{"key":"787_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt255","volume":"6","author":"O Hansson","year":"2014","unstructured":"Hansson, O. et al. Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimers Res. Ther. 6, 25 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"787_CR52","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/mds.28611","volume":"36","author":"NK Majbour","year":"2021","unstructured":"Majbour, N. K. et al. Cerebrospinal \u03b1-synuclein oligomers reflect disease motor severity in DeNoPa Longitudinal Cohort. Mov. Disord. 36, 2048\u20132056 (2021).","journal-title":"Mov. Disord."},{"key":"787_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/19336896.2020.1724608","volume":"14","author":"J-Y Han","year":"2020","unstructured":"Han, J.-Y., Jang, H.-S., Green, A. J. E. & Choi, Y. P. RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy. Prion 14, 88\u201394 (2020).","journal-title":"Prion"},{"key":"787_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne, S. et al. \u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov. Disord. 35, 268\u2013278 (2020).","journal-title":"Mov. Disord."},{"key":"787_CR55","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","volume":"6","author":"M Bongianni","year":"2019","unstructured":"Bongianni, M. et al. \u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann. Clin. Transl. Neurol. 6, 2120\u20132126 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"787_CR56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/v13050759","volume":"13","author":"J-Y Han","year":"2021","unstructured":"Han, J.-Y., Shin, C. & Choi, Y. P. Preclinical detection of alpha-synuclein seeding activity in the colon of a transgenic mouse model of synucleinopathy by RT-QuIC. Viruses 13, 759 (2021).","journal-title":"Viruses"},{"key":"787_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","volume":"9","author":"C Bargar","year":"2021","unstructured":"Bargar, C. et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. Commun. 9, 62 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"787_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo, A. et al. Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 20, 203\u2013212 (2021).","journal-title":"Lancet Neurol."},{"key":"787_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca, C. M. G. et al. Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl. Neurodegener. 8, 24 (2019).","journal-title":"Transl. Neurodegener."},{"key":"787_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcab045","volume":"3","author":"D Perra","year":"2021","unstructured":"Perra, D. et al. Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies. Brain Commun. 3, 1\u201311 (2021).","journal-title":"Brain Commun."},{"key":"787_CR61","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","volume":"144","author":"A Stefani","year":"2021","unstructured":"Stefani, A. et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain 144, 1118\u20131126 (2021).","journal-title":"Brain"},{"key":"787_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","volume":"88","author":"W Singer","year":"2020","unstructured":"Singer, W. et al. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy Body synucleinopathies. Ann. Neurol. 88, 503\u2013512 (2020).","journal-title":"Ann. Neurol."},{"key":"787_CR63","first-page":"1","volume":"78","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 78, 1\u201311 (2020).","journal-title":"JAMA Neurol."},{"key":"787_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.1","volume":"49","author":"BC Jung","year":"2017","unstructured":"Jung, B. C. et al. Amplification of distinct \u03b1-synuclein fibril conformers through protein misfolding cyclic amplification. Exp. Mol. Med. 49, e314 (2017).","journal-title":"Exp. Mol. Med."},{"key":"787_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2019.05.002","volume":"129","author":"A Fenyi","year":"2019","unstructured":"Fenyi, A. et al. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification. Neurobiol. Dis. 129, 38\u201343 (2019).","journal-title":"Neurobiol. Dis."},{"key":"787_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"787_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/0929866527666200420105352","volume":"28","author":"S-J Park","year":"2021","unstructured":"Park, S.-J. et al. Establishment of method for the determination of aggregated \u03b1-synuclein in DLB patient using RT-QuIC assay. Protein Pept. Lett. 28, 115\u2013120 (2021).","journal-title":"Protein Pept. Lett."},{"key":"787_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42399-0","volume":"9","author":"K Kakuda","year":"2019","unstructured":"Kakuda, K. et al. Ultrasonication-based rapid amplification of \u03b1-synuclein aggregates in cerebrospinal fluid. Sci. Rep. 9, 6001 (2019).","journal-title":"Sci. Rep."},{"key":"787_CR69","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ana.26089","volume":"89","author":"W Singer","year":"2021","unstructured":"Singer, W. et al. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure. Ann. Neurol. 89, 1212\u20131220 (2021).","journal-title":"Ann. Neurol."},{"key":"787_CR70","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.febslet.2006.02.032","volume":"580","author":"M Masuda","year":"2006","unstructured":"Masuda, M. et al. Cysteine misincorporation in bacterially expressed human \u03b1-synuclein. FEBS Lett. 580, 1775\u20131779 (2006).","journal-title":"FEBS Lett."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41596-022-00787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-022-00787-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-022-00787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:08:49Z","timestamp":1681211329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-022-00787-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1038\/s41596-022-00787-3","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.C.-M. and C.M.F. are employees of Amprion Inc., a biotechnology company that focuses on the commercial use of SAAs (PMCA and RT-QuIC) for high-sensitivity detection of misfolded protein aggregates. C.S. is a Founder, Chief Scientific Officer and Member of the Board of Directors of Amprion Inc. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}